top of page
Executive Spotlights

Johnson & Johnson MedTech Acquires Laminar for $400M

New Brunswick, NJ, November 30, 2023 (Johnson & Johnson) -- Johnson & Johnson MedTech has completed the acquisition of Laminar, Inc., a medical device company specializing in non-valvular atrial fibrillation (AFib). The initial payment was $400 million, with possible additional payments in 2024 and beyond. Laminar is now integrated into Biosense Webster, Inc., a leading name in cardiac arrhythmia treatment within the Johnson & Johnson MedTech portfolio.

Read full article here.

Recent Posts

See All

Radiant Vision Systems Appoints new CEO

Redmond, WA, July 1, 2024 (Radiant) -- Radiant Vision Systems has appointed Stone Jiang as their new CEO, succeeding Doug Kreysar who is retiring. Jiang, previously the Executive Vice President and

Orion and Merck Secure $1.63B Agreement

Rahway, NJ, July 1, 2024 (Business Wire) -- Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, and Orion Corporation ("Orion") have agreed to convert their co-development and co-commercial


Life Science Headlines
bottom of page